Drug intelligence / Profile preview

dexamethasone + gentamicin + vitamin B12 + procaine

Development stage: Unknown
Lead developer: Merck
Modality: Small Molecules
Administration: Intramuscular, Local Injection, Perineural Injection

Overview

A combination drug containing dexamethasone (a corticosteroid), gentamicin (an aminoglycoside antibiotic), vitamin B12 (cyanocobalamin), and procaine (a local anesthetic). Dexamethasone provides anti-inflammatory effects, gentamicin offers antimicrobial activity, vitamin B12 supports nerve function and repair, and procaine contributes local anesthetic properties. This combination may be used for conditions involving inflammation, infection, and neuropathic pain.

Targets

GR (Glucocorticoid receptor)Bacterial RibosomeNaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on dexamethasone + gentamicin + vitamin B12 + procaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone + gentamicin + vitamin B12 + procaine.

Explore the full profile